Comparison of Strut Coverage With OPTIMAX Versus SYNERGY Stents

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 110 participants.

Also called NCT02464397

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 110 participants (planned count) (from the registry)
Sponsor
The Hospital District of Satakunta (from the registry)
Registry
  • NCT NCT02464397
Other papers using this trial's data
  • Comparative study of neointimal coverage between titanium-nitric oxide-coated and everolimus-eluting stents in acute coronary syndromes Revista espanola de cardiologia (English ed.), 2023-03 DOI, PubMed 35752571

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, Finland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02464397. Randomized; single masking; primary purpose treatment. Start 2015-02 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Strut Coverage With OPTIMAX Versus SYNERGY Stents
Acronym
OPTIMAX-OCT
Condition
Acute Coronary Syndrome
Intervention (Device)
Stent
Lead sponsor
The Hospital District of Satakunta (class: other)

Record details

Record id
cardio:ct-nct02464397
Content hash
23c543a1f37cebeef1f2b34d0dbc2cb737c84512c592ff259567256a47af7767